MaterniT21® is the first noninvasive prenatal test (NIPT) of its kind for women at high risk of foetal chromosomal abnormalities. It is valid for singleton and multiple pregnancies, gender and Trisomies 13, 18 and 21.
US billing and insurance details are NOT applicable in NZ
There is a 2.5 percent surcharge on Visa and MasterCard transactions.
MaterniT21® PLUS adds an enhanced sequencing panel of four sex chromosomal abnormalities, eight specific microdeletions and Trisomies 16 and 22.
US billing and insurance details are NOT applicable in NZ
There is a 2.5 percent surcharge on Visa and MasterCard transactions.
MaterniTTM GENOME is the most comprehensive NIPT available, interrogating all chromosomes to identify significant losses or gains of genetic material.
US billing and insurance details are NOT applicable in NZ
There is a 2.5 percent surcharge on Visa and MasterCard transactions.